Literature DB >> 20026796

"I am older, not elderly," said the patient with acute myeloid leukemia.

Charles A Schiffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20026796     DOI： 10.1200/JCO.2009.25.8616

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

Review 1.  The artful management of older patients with acute myeloid leukemia.

Authors:  Jay Yang; Charles A Schiffer
Journal:  Expert Rev Hematol       Date:  2016-03-02       Impact factor: 2.929

Review 2.  Cytotoxic therapy in acute myeloid leukemia: not quite dead yet.

Authors:  Laura C Michaelis
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  The benefit of population-based studies for older patients with acute myeloid leukemia.

Authors:  Ulrike Bacher; Torsten Haferlach
Journal:  Haematologica       Date:  2012-12       Impact factor: 9.941

Review 4.  Reduced-intensity conditioning allogeneic hematopoietic-cell transplantation for older patients with acute myeloid leukemia.

Authors:  Gaurav Goyal; Krishna Gundabolu; Saraschandra Vallabhajosyula; Peter T Silberstein; Vijaya Raj Bhatt
Journal:  Ther Adv Hematol       Date:  2016-04-22

5.  A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy.

Authors:  Michael Lübbert; Björn H Rüter; Rainer Claus; Claudia Schmoor; Mathias Schmid; Ulrich Germing; Andrea Kuendgen; Volker Rethwisch; Arnold Ganser; Uwe Platzbecker; Oliver Galm; Wolfram Brugger; Gerhard Heil; Björn Hackanson; Barbara Deschler; Konstanze Döhner; Anne Hagemeijer; Pierre W Wijermans; Hartmut Döhner
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

6.  Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy.

Authors:  Salih Subari; Firas Baidoun; Muhanad Hreh; Mrinal Patnaik; Shahrukh Hashmi; Michelle Elliott; William Hogan; Mark Litzow; Aref Al-Kali
Journal:  Int J Hematol       Date:  2016-01-18       Impact factor: 2.490

7.  Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia.

Authors:  Hagop Kantarjian; Farhad Ravandi; Susan O'Brien; Jorge Cortes; Stefan Faderl; Guillermo Garcia-Manero; Elias Jabbour; William Wierda; Tapan Kadia; Sherry Pierce; Jianqin Shan; Michael Keating; Emil J Freireich
Journal:  Blood       Date:  2010-07-28       Impact factor: 22.113

8.  "Epigenetic" modification as therapy for acute myeloid leukemia.

Authors:  Charles A Schiffer
Journal:  Cancer       Date:  2017-12-06       Impact factor: 6.860

9.  A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia.

Authors:  Sucha Nand; Megan Othus; John E Godwin; Cheryl L Willman; Thomas H Norwood; Dianna S Howard; Steven E Coutre; Harry P Erba; Frederick R Appelbaum
Journal:  Blood       Date:  2013-10-03       Impact factor: 22.113

10.  Allogeneic hematopoietic cell transplantation in septuagenarians.

Authors:  Michael R Grunwald
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-18       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.